All tenders

Contrast Anthropomorphic Breast Phantoms

Ref US-75F40123Q00399Advertised11 Sept 2023Closing 18 Sept 2023

Tender Description

Notice type: Special Notice · NAICS 334516 · PSC 6640 The U.S. Food & Drug Administration (FDA) intends to issue a Sole Source award to Phantomx GMBH. The Government intends to issue a sole source award in accordance with FAR 6.302-1, only one responsible source and no other will satisfy the agency requirements for the above stated service. The scope of the work is to provide breast phantoms. One phantom shall have a uniform background breast shape emulating x-ray attenuation of adipose tissue with 10, 10 mm long cylinders of radius 5 mm , two masses with each iodine concentration of 0.25 mg/ml, 0.5 mg/ml, 1.0 mg/ml, and 2.0 mg/ml The other four phantoms shall have anthropomorphic breast background structure matching a virtual breast phantom supplied by the FDA. The NAICS Code is: 334516 Analytical Laboratory Instrument Manufacturing. The Vendor to be awarded: Phantomx GMBH Schwedenster.14 Berlin Germany This will be a firm fixed price award for a Base Period and four (4) one (1) year Option Periods. This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement to Iris Johnson, Iris.Johnson1@fda.hhs.gov in writing and must be within five (5) days after date of publication of this notice which may be considered by the agency. A determination by the Government not to compete as a result of information received is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No phone calls will be accepted.

Country
United States
Published
11 Sept 2023
Closing date
18 Sept 2023
Procedure
Special Notice
Predictive Analytics
Notice sources